Qrons Inc is an innovative biotechnology company headquartered in New York City, with research centered in Israel. They are dedicated to developing products and treatments to combat neuronal and infectious diseases, with a particular focus on antibiotic resistant bacteria, which is a rapidly growing worldwide cause of illness and death. Qrons utilizes proprietary synthetic hydrogels and Tellurium based compounds as building blocks for their developed products and treatments.
With a mission to fight against neuronal and infectious diseases, Qrons seeks strategic collaborations with companies, universities, and scientists who possess unique expertise and intellectual properties in the fields of stem cells, antibiotic resistant drug development, and tissue engineering. Their goal is to deploy these resources in the ongoing battle against these diseases, which pose significant global health challenges.
Generated from the website